Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

By MELINDA J. OVERSTREET for Glasgow News 1 In September 2023, he had been fighting a cold for weeks and weeks. His immune ...

A credit-card-sized chip may soon outsmart cancer.A team led by NYU Tandon School of Engineering’s Weiqiang Chen has ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could ...

The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

While the sun is a welcome sight for many during this holiday weekend, it means you can get sunburned in 15 minutes or less ...

The U.S. Food and Drug Administration has approved Regeneron Pharmaceuticals' Lynozyfic, a therapy for recurrent multiple myeloma, boosting the company's shares by 2%.

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

Dale Shepard, MD, PhD, discusses the key themes emerging from the 2025 ASCO Annual Meeting, highlighting a prevailing sense ...

NASHVILLE, Tenn. (WTVF) — June is Cancer Immunotherapy Month. Immunotherapy drugs have been on the market for more than a ...